Table 3
Open in new tab

DPB1 alleles in PR3-AAV patients and controls

PR3-AAV patients (n = 140)Controls (n = 1070)
*04:01/*01:011 (0.7%)64 (6.0%)
*04:01/*02:016 (4.3%)113 (10.6%)
*04:01/*02:022 (1.4%)4 (0.4%)
*04:01/*03:012 (1.4%)97 (9.1%)
*04:01/*04:0184 (60.0%)257 (24.0%)
*04:01/*04:0231 (22.1%)123 (11.5%)
*04:01/*05:011 (0.7%)21 (2.0%)
*04:01/*06:011 (0.7%)14 (1.3%)
*04:01/*09:011 (0.7%)4 (0.4%)
*04:01/*23:013 (2.1%)5 (0.5%)
*04:01/other0 (0%)77 (7.2%)
*04:02/*02:010 (0%)25 (2.3%)
*04:02/*02:020 (0%)2 (0.2%)
*04:02/*03:013 (2.1%)24 (2.2%)
*04:02/*04:024 (2.9%)15 (1.4%)
*04:02/*23:011 (0.7%)0 (0%)
*04:02/other0 (0%)47 (4.4%)
*23:01/other0 (0%)3 (0.3%)
Other/other0 (0%)175 (16.4%)
Carrier of *04:01132 (94%)779 (72.8%)
Carrier of *04:01 or 04:02140 (100%)892 (83.4%)
*04:01 or *04:02/*04:01 or *04:02119 (85%)395 (36.9%)
*04:01 or *04:02/*04:01 or *04:02 or *23:01123 (88%)400 (37.4%)
Carrier of *02:016 (4.3%)207 (19.3%)
PR3-AAV patients (n = 140)Controls (n = 1070)
*04:01/*01:011 (0.7%)64 (6.0%)
*04:01/*02:016 (4.3%)113 (10.6%)
*04:01/*02:022 (1.4%)4 (0.4%)
*04:01/*03:012 (1.4%)97 (9.1%)
*04:01/*04:0184 (60.0%)257 (24.0%)
*04:01/*04:0231 (22.1%)123 (11.5%)
*04:01/*05:011 (0.7%)21 (2.0%)
*04:01/*06:011 (0.7%)14 (1.3%)
*04:01/*09:011 (0.7%)4 (0.4%)
*04:01/*23:013 (2.1%)5 (0.5%)
*04:01/other0 (0%)77 (7.2%)
*04:02/*02:010 (0%)25 (2.3%)
*04:02/*02:020 (0%)2 (0.2%)
*04:02/*03:013 (2.1%)24 (2.2%)
*04:02/*04:024 (2.9%)15 (1.4%)
*04:02/*23:011 (0.7%)0 (0%)
*04:02/other0 (0%)47 (4.4%)
*23:01/other0 (0%)3 (0.3%)
Other/other0 (0%)175 (16.4%)
Carrier of *04:01132 (94%)779 (72.8%)
Carrier of *04:01 or 04:02140 (100%)892 (83.4%)
*04:01 or *04:02/*04:01 or *04:02119 (85%)395 (36.9%)
*04:01 or *04:02/*04:01 or *04:02 or *23:01123 (88%)400 (37.4%)
Carrier of *02:016 (4.3%)207 (19.3%)
a

Data are presented as n (%).

Table 3
Open in new tab

DPB1 alleles in PR3-AAV patients and controls

PR3-AAV patients (n = 140)Controls (n = 1070)
*04:01/*01:011 (0.7%)64 (6.0%)
*04:01/*02:016 (4.3%)113 (10.6%)
*04:01/*02:022 (1.4%)4 (0.4%)
*04:01/*03:012 (1.4%)97 (9.1%)
*04:01/*04:0184 (60.0%)257 (24.0%)
*04:01/*04:0231 (22.1%)123 (11.5%)
*04:01/*05:011 (0.7%)21 (2.0%)
*04:01/*06:011 (0.7%)14 (1.3%)
*04:01/*09:011 (0.7%)4 (0.4%)
*04:01/*23:013 (2.1%)5 (0.5%)
*04:01/other0 (0%)77 (7.2%)
*04:02/*02:010 (0%)25 (2.3%)
*04:02/*02:020 (0%)2 (0.2%)
*04:02/*03:013 (2.1%)24 (2.2%)
*04:02/*04:024 (2.9%)15 (1.4%)
*04:02/*23:011 (0.7%)0 (0%)
*04:02/other0 (0%)47 (4.4%)
*23:01/other0 (0%)3 (0.3%)
Other/other0 (0%)175 (16.4%)
Carrier of *04:01132 (94%)779 (72.8%)
Carrier of *04:01 or 04:02140 (100%)892 (83.4%)
*04:01 or *04:02/*04:01 or *04:02119 (85%)395 (36.9%)
*04:01 or *04:02/*04:01 or *04:02 or *23:01123 (88%)400 (37.4%)
Carrier of *02:016 (4.3%)207 (19.3%)
PR3-AAV patients (n = 140)Controls (n = 1070)
*04:01/*01:011 (0.7%)64 (6.0%)
*04:01/*02:016 (4.3%)113 (10.6%)
*04:01/*02:022 (1.4%)4 (0.4%)
*04:01/*03:012 (1.4%)97 (9.1%)
*04:01/*04:0184 (60.0%)257 (24.0%)
*04:01/*04:0231 (22.1%)123 (11.5%)
*04:01/*05:011 (0.7%)21 (2.0%)
*04:01/*06:011 (0.7%)14 (1.3%)
*04:01/*09:011 (0.7%)4 (0.4%)
*04:01/*23:013 (2.1%)5 (0.5%)
*04:01/other0 (0%)77 (7.2%)
*04:02/*02:010 (0%)25 (2.3%)
*04:02/*02:020 (0%)2 (0.2%)
*04:02/*03:013 (2.1%)24 (2.2%)
*04:02/*04:024 (2.9%)15 (1.4%)
*04:02/*23:011 (0.7%)0 (0%)
*04:02/other0 (0%)47 (4.4%)
*23:01/other0 (0%)3 (0.3%)
Other/other0 (0%)175 (16.4%)
Carrier of *04:01132 (94%)779 (72.8%)
Carrier of *04:01 or 04:02140 (100%)892 (83.4%)
*04:01 or *04:02/*04:01 or *04:02119 (85%)395 (36.9%)
*04:01 or *04:02/*04:01 or *04:02 or *23:01123 (88%)400 (37.4%)
Carrier of *02:016 (4.3%)207 (19.3%)
a

Data are presented as n (%).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close